Research from the laboratory of Dr. Edgar Hartsuiker at the Bangor North West Cancer Research Institute, School of Medical Sciences, has been published in the latest issue (29 May) of the high-ranking journal Science Advances.
2 hours ago
0
0
A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells ...
20 hours ago
0
2
Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of ...
Jun 02, 2020
0
91
Scientific evidence suggests that cancer can metastasize to other organs when either a single cell or a cluster of cells detaches from the original tumor and travels through the blood to another location, where it grows into ...
Jun 01, 2020
0
48
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial ...
May 29, 2020
0
1
A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy ...
May 28, 2020
0
84
Efforts to design a safe vaccine for COVID-19 are moving forward at full throttle, yet experts agree that it's likely to be a year, at least, before an immunisation is ready. Meanwhile, scientists around Europe are exploring ...
May 26, 2020
0
10
Genes that perform critical but mundane tasks within cells—such as generating energy or eliminating waste—haven't traditionally been considered prime targets for cancer therapy. A new study led by Caitlin Nichols, Brenton ...
May 25, 2020
0
0
Adoptive T cell therapies, including chimeric antigen receptor (CAR) T cell therapy, which use genetically engineered killer immune T cells, are emerging forms of immunotherapy that redirect the immune system to target cancer.
May 19, 2020
0
80
Trial results presented today revealed a promising therapy for patients experiencing angina due to coronary microvascular dysfunction (CMD). The results of the study were presented today as feature clinical research during ...
May 14, 2020
0
1
